Penn Medicine Abramson Cancer Center
G

Penn Medicine Melanoma Management During COVID-19: What Safety Measures Were Implemented in the OR? How Should We Interpret NCCN Guidelines and Weigh Them Against the Local Practice?

By Penn Medicine Abramson Cancer Center FEATURING Giorgos Karakousis, Christopher J. Miller
By Penn Medicine Abramson Cancer Center FEATURING Giorgos Karakousis, Christopher J. Miller
61 views
November 16, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
13:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…

Feat. V. Subbiah
23:09
Total Health

Key Updates in Skin Melanoma

Feat. R. Seedor
06:39
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Analysis of Distant Metastasis-Free…

Feat. J. Luke
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
17:39
Melanoma Bridge 2023

Major Emerging Paradigm Shifts That Will Change Melanoma Management …

Feat. A. Eggermont
05:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…

Feat. E. Buchbinder
08:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 3 Trial Comparing Fianlimab + Cem…

Feat. T. Panella
19:52
OncoAlert

Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…

Feat. A. Betof Warner
21:04
Penn Medicine Abramson Cancer Center

Pediatric Melanoma

Feat. M. Jen
05:37
Melanoma Bridge 2023

COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…

Feat. R. Dummer
08:46
Sapna Patel

Neoadjuvant Immunotherapy in the Treatment of Melanoma: What Do We K…

13:12
2023 Year in Review

Year in Review: Surgical Treatment of Acral Melanoma

Feat. M. Leventer
52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
14:00
Melanoma Bridge 2023

Is SLN Biopsy No Longer Necessary for Patients With High-Risk Primar…

Feat. J. Luke
08:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Significant Durable Response With Fianlim…

Feat. O. Hamid
30:29
NYU Langone

Updates in Treatment with Immunotherapy for Melanoma and Related Mal…

Feat. J. Weber
20:55
2023 West Oncology Conference

2023 West Oncology Conference: Melanoma Updates

Feat. M. Mooradian
25:10
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Immunotherapy Combinations in Melanoma in 2024

Feat. J. Moyers